| |APRIL 20266VIVID OUTLOOKWhy Global Pharma Expects CDMOs to Be Ready for Joint InspectionsBalancing Innovation and Affordability in Medical Solutions for IndiaHow PLI Scheme is Reshaping India's Drug Production FutureAshutosh K Sinha, Chief Quality Officer, Neuland LaboratoriesRajiv Gupta, Country Business Leader (Healthcare Business), 3M IndiaVikram Aditya Sehgal, Director ­ Finance, Centrient India243034VANTAGE POINT1214THOUGHT CENTRALAFTERWORDPatient Twinning & Its Impact on Clinical Decision-MakingNavigating the New Era of Nitrosamine ComplianceDileep Mangsuli, Senior Vice President - Global Access to Care, Siemens HealthineersAmit Chopra, Chief Executive Officer - South Asia and Middle East, Cotecna GroupBridging Collaboration Gaps to Boost India's Pharma DiscoveryDr Sadhna Joglekar, Senior VP & Head - Global Drug Development India, Novartis38
< Page 5 | Page 7 >